Holick MF - Search Results

1

Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, Garland CF, Giovannucci E. Cannell JJ, et al. Among authors: holick mf. Epidemiol Infect. 2006 Dec;134(6):1129-40. doi: 10.1017/S0950268806007175. Epub 2006 Sep 7. Epidemiol Infect. 2006. PMID: 16959053 Free PMC article. Review.

2

Benefits and requirements of vitamin D for optimal health: a review.

Grant WB, Holick MF. Grant WB, et al. Among authors: holick mf. Altern Med Rev. 2005 Jun;10(2):94-111. Altern Med Rev. 2005. PMID: 15989379 Review.

3

Oral vitamin D₃ supplementation increases serum fibroblast growth factor 23 concentration in vitamin D-deficient patients: a systematic review and meta-analysis.

Charoenngam N, Rujirachun P, Holick MF, Ungprasert P. Charoenngam N, et al. Among authors: holick mf. Osteoporos Int. 2019 Nov;30(11):2183-2193. doi: 10.1007/s00198-019-05102-7. Epub 2019 Aug 1. Osteoporos Int. 2019. PMID: 31372708

4

Vitamin D requirements for humans of all ages: new increased requirements for women and men 50 years and older.

Holick MF. Holick MF. Osteoporos Int. 1998;8 Suppl 2:S24-9. doi: 10.1007/pl00022729. Osteoporos Int. 1998. PMID: 10197179 Review. No abstract available.

5

Vitamin D insufficiency together with high serum levels of vitamin A increases the risk for osteoporosis in postmenopausal women.

Mata-Granados JM, Cuenca-Acevedo JR, Luque de Castro MD, Holick MF, Quesada-Gómez JM. Mata-Granados JM, et al. Among authors: holick mf. Arch Osteoporos. 2013;8:124. doi: 10.1007/s11657-013-0124-5. Epub 2013 Feb 16. Arch Osteoporos. 2013. PMID: 23417776

6

An international comparison of serum 25-hydroxyvitamin D measurements.

Lips P, Chapuy MC, Dawson-Hughes B, Pols HA, Holick MF. Lips P, et al. Among authors: holick mf. Osteoporos Int. 1999;9(5):394-7. doi: 10.1007/s001980050162. Osteoporos Int. 1999. PMID: 10550457

7

High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors.

Erkal MZ, Wilde J, Bilgin Y, Akinci A, Demir E, Bödeker RH, Mann M, Bretzel RG, Stracke H, Holick MF. Erkal MZ, et al. Among authors: holick mf. Osteoporos Int. 2006;17(8):1133-40. doi: 10.1007/s00198-006-0069-2. Epub 2006 May 23. Osteoporos Int. 2006. PMID: 16718398

8

Treatment of psoriatic arthritis with oral 1,25-dihydroxyvitamin D3: a pilot study.

Huckins D, Felson DT, Holick M. Huckins D, et al. Arthritis Rheum. 1990 Nov;33(11):1723-7. doi: 10.1002/art.1780331117. Arthritis Rheum. 1990. PMID: 2242069

9

Topical H2 antagonist prevents periodontitis in a rabbit model.

Hasturk H, Kantarci A, Ebrahimi N, Andry C, Holick M, Jones VL, Van Dyke TE. Hasturk H, et al. Infect Immun. 2006 Apr;74(4):2402-14. doi: 10.1128/IAI.74.4.2402-2414.2006. Infect Immun. 2006. PMID: 16552070 Free PMC article.

10

Administration of DAB389IL-2 to patients with recalcitrant psoriasis: a double-blind, phase II multicenter trial.

Bagel J, Garland WT, Breneman D, Holick M, Littlejohn TW, Crosby D, Faust H, Fivenson D, Nichols J. Bagel J, et al. J Am Acad Dermatol. 1998 Jun;38(6 Pt 1):938-44. doi: 10.1016/s0190-9622(98)70590-0. J Am Acad Dermatol. 1998. PMID: 9632001 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

614 results

Search Page

Filters